Table 7. .
CNP BAC ID | Chromosome and hg16 Coordinates | ACNFa | Best Available SNP | SNP R2 | LOD |
RP11-97F19 | 2: 89779383–89954029 | .04 | rs7583495 | .15 | 2.49 |
CTD-3065P9 | 4: 70432218–70591332 | .41 | rs11249532 | 1.00 | 23.93 |
RP11-177L24 (CNP loss) | 10: 46859266–47011568 | .03 | rs7901145 | .11 | 1.85 |
RP11-177L24 (CNP gain) | 10: 46859266–47011568 | .03 | rs11259816 | .33 | 1.65 |
RP11-958F14 | 11: 55221653–55393983 | .07 | rs7950741 | .09 | 2.26 |
RP11-261P7+RP11-1068E21b | 15: 28207785–28499440 | .17 | rs2140173 | .18 | 3.15 |
RP11-141H9 | 17: 45061319–45230413 | .42 | rs199455 | .29 | 6.36 |
RP11-1143M16 | 22: 24050173–24204080 | .02 | rs2092184 | 1.00 | 4.40 |
Note.— Analysis of LD across the CNP regions allowed the identification of a best available SNP in a subset of the discrete CNP sites. Significant LOD scores >3.0 (shown in bold italics) were observed for only 4 of the 19 sites and/or allelic states tested.
ACNF is within the YRI subpopulation.
Note that the two overlapping BAC clones RP11-261P7 and RP11-1068E21 were analyzed as a single variant site.